store at low temperature
Mirzotamab, an IgG1κ antibody, targets CD276/B7-H3 and conjugates with Clezutoclax, a BCL-2 inhibitor, to create Mirzotamab clezutoclax. This antibody-drug conjugate (ADC), identified as ABBV-155, is currently under investigation in conjunction with taxane research in the treatment of relapsed/refractory solid tumors [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 263.00 | |
5 mg | In stock | $ 689.00 | |
10 mg | In stock | $ 1,120.00 | |
25 mg | In stock | $ 1,670.00 | |
50 mg | In stock | $ 2,250.00 | |
100 mg | In stock | $ 2,970.00 |
Description | Mirzotamab, an IgG1κ antibody, targets CD276/B7-H3 and conjugates with Clezutoclax, a BCL-2 inhibitor, to create Mirzotamab clezutoclax. This antibody-drug conjugate (ADC), identified as ABBV-155, is currently under investigation in conjunction with taxane research in the treatment of relapsed/refractory solid tumors [1]. |
Molecular Weight | N/A |
CAS No. | 2229859-11-2 |
store at low temperature
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mirzotamab 2229859-11-2 inhibitor inhibit